MSD, Bayer’s heart failure med Verquvo gains EU approval

22nd July 2021 Uncategorised 0

Verquvo cleared for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction

More: MSD, Bayer’s heart failure med Verquvo gains EU approval
Source: News